NVS financials
Novartis (NVS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
NVS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $54.81B | $41.12B | $17.07B | $14.06B | 7.19 |
| 2024 | $51.72B | $38.90B | $14.54B | $11.94B | 5.87 |
| 2023 | $46.66B | $34.19B | $9.77B | $14.85B | 7.10 |
| 2022 | $43.46B | $31.88B | $7.95B | $6.96B | 3.17 |
| 2021 | $43.97B | $32.24B | $10.06B | $24.02B | 10.63 |
| 2020 | $49.90B | $34.78B | $10.15B | $8.07B | 3.52 |
- NVS revenue was $54.81B in fiscal 2025, net income $14.06B.
Updated 2026-11-02 19:55 UTC